Fine-grained glomerular subtyping is essential for kidney biopsy interpretation, yet it presents a harder setting than the broad organ- or disease-level recognition tasks commonly used in vision-language model (VLM) evaluation. In this task, all categories arise within the same renal microanatomic unit, and clinically meaningful subtypes often differ by subtle, overlapping, and continuum-like morphological cues. Clinically valuable labels are also scarce, making fully supervised image-only paradigms difficult to translate to practice. Although VLMs are promising for data-efficient pathology learning, it remains unclear how their cross-modal representations should be adapted and evaluated for such within-structure discrimination under realistic few-shot constraints. To our knowledge, this study establishes the first fine-grained renal pathology benchmark for few-shot VLM adaptation and systematically examines how supervision level, model design, and adaptation strategy shape both classification performance and multimodal representation structure. Beyond accuracy, area under the receiver operating characteristic curve (AUC), F1 score, image-text alignment, positive-negative similarity separation, embedding geometry, and confidence calibration quantified by expected calibration error (ECE), we ask when performance gains reflect more reliable cross-modal understanding. Across renal pathology cohorts, additional supervision consistently improves discrimination, but reliable adaptation is not explained by alignment alone; stronger performance is associated with larger class separation, more coherent embedding organization, and better awareness of confidence-related failure modes under domain variation. Within this retrospective two-cohort evaluation, these findings move assessment beyond coarse classification and accuracy alone and provide comparative evidence to inform model selection and future translational validation. Our implementation has now been publicly released for reproducibility on GitHub at https://github.com/ddrrnn123/glo-vlms
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: